[Diabetes and autoimmune diseases. II]. / Diabete e malattie autoimmuni. Parte II.

Antipancreas autoimmunity is one of several immunity problems in diabetes. Such of its features as are revealed by inhibition of leukocyte migration, lymphocyte transformation in response to insulin antigens, relation between cell autoimmunity and later complications, and the behaviour of peripheral T and B lymphocyte membrane markers are explained. The aetiological role of viral infections is discussed, and the pathogenetic hypothesis deducible from the histological findings. Lastly, the modalities underlying a combination between the HLA (human leukocyte antigen) system and diabetes are considered.

[Clinical observations on the treatment of ischemic cardiac disease with a calcium antagonist: nifedipine]. / Osservazioni cliniche sul trattamento della cardiopatia ischemica con un calcio-antagonista: la Nifedipina.

Results obtained wih Nifedipine in 146 coronary patients, 85 of them suffering from coronaro-sclerosis with rest and effort stenocardic attacks, and 61 with post-infarctual stenocardic signs, are reported. In 76% of patients in the first group and in 85% of those in the second, pain symptomatology disappeared rapidly; ECGs also showed attenuation and modification, particularly among angina patients. The drug also led to a reduction in hypertension.

[HBsAg and viral hepatitis in a hemodialysis center (author's transl)]. / HBsAg ed epatite virale in un centro di emodialisi.

The behaviour of HBsAg and hepatitis B in 86 patients and in 24 medical personnel of a hemodialysis Center during 5 years is described. Hepatitis B antigen was detected in 28 patients (32.55%); hepatitis B infection developed in 7 of them and in 2 of the medical staff. Some problems of prevention and therapy are discussed.